Oligonucleotide, Therapy, and Applications

Oligonucleotides (ON) constitute a new group of molecular agents, the object of significant interest due to their potential value as drugs for diagnostic and therapeutic applications. Their special interest derives from the intrinsic characteristics of ONs: a) ONs are informative agents, a property...

Olles dieđut

Furkejuvvon:
Bibliográfalaš dieđut
Materiálatiipa: Online
Giella:eaŋgalasgiella
Almmustuhtton: MDPI - Multidisciplinary Digital Publishing Institute 2022
Fáttát:
Liŋkkat:ONIX_20220321_9783036530574_7
Fáddágilkorat: Lasit fáddágilkoriid
Eai fáddágilkorat, Lasit vuosttaš fáddágilkora!
_version_ 1869517049900826624
collection Directory of Open Access Books
description Oligonucleotides (ON) constitute a new group of molecular agents, the object of significant interest due to their potential value as drugs for diagnostic and therapeutic applications. Their special interest derives from the intrinsic characteristics of ONs: a) ONs are informative agents, a property that derives from the order in which the nucleotides of each particular ON are arranged; b) ONs can act as ligands (ASO, TFO, aptamers, G-quadruplex, etc.) of complementary nucleic acid sequences (DNA or RNA) due to their high capacity to hybridize (by means of Watson and Crick or Hoogsteen links) with other nucleotide sequences, resulting in specific gene modulatory effects. However, nonspecific sequences may also be of interest, as is the case with repetitive nucleotide sequences (CpG) with adjuvant effects of vaccines; c) ONs can also rapidly evolve to achieve specific advantages of utility (targeting, stability, efficacy, toxicity, etc.) or high-sensitivity diagnostic technology (markers, analyzes, biosensors, FISH, microarrays, etc.), by chemical modification of nucleotides in any of their atoms. These properties show that ONs are first-order molecules due to their potential usefulness in practice.In this collection of research articles and review papers, we aim to highlight their therapeutic, but also diagnostic and technological utility as drugs.
format Online
id doab-20.500.12854ir-79571
institution Directory of Open Access Books
language eng
publishDate 2022
publishDateRange 2022
publishDateSort 2022
publisher MDPI - Multidisciplinary Digital Publishing Institute
publisherStr MDPI - Multidisciplinary Digital Publishing Institute
record_format ojs
spelling doab-20.500.12854ir-795712024-03-30T23:22:01Z Oligonucleotide, Therapy, and Applications Aliño, Salvador Sendra, Luis quantum dots (QDs) DNAzyme ROS Amplex Red light-induced activity DNA methylation histone code microRNA nanoparticles noncoding RNA pulmonary arterial hypertension aptamer aptasensor influenza SERS virus detection α-synuclein antisense oligonucleotide dopamine neurotransmission double mutant A30P*A53T* motor deficits Parkinson’s disease transgenic mouse model G-quadruplexes covalent dimer construct anti-proliferative activity primary cell culture of human glioma antisensense oligonucleotide Foxp3 regulatory T cells vaccine immunogenicity Sporothrix schenckii Marfan syndrome fibrillin-1 antisense oligonucleotides exon skipping splice-switching thema EDItEUR::M Medicine and Nursing Oligonucleotides (ON) constitute a new group of molecular agents, the object of significant interest due to their potential value as drugs for diagnostic and therapeutic applications. Their special interest derives from the intrinsic characteristics of ONs: a) ONs are informative agents, a property that derives from the order in which the nucleotides of each particular ON are arranged; b) ONs can act as ligands (ASO, TFO, aptamers, G-quadruplex, etc.) of complementary nucleic acid sequences (DNA or RNA) due to their high capacity to hybridize (by means of Watson and Crick or Hoogsteen links) with other nucleotide sequences, resulting in specific gene modulatory effects. However, nonspecific sequences may also be of interest, as is the case with repetitive nucleotide sequences (CpG) with adjuvant effects of vaccines; c) ONs can also rapidly evolve to achieve specific advantages of utility (targeting, stability, efficacy, toxicity, etc.) or high-sensitivity diagnostic technology (markers, analyzes, biosensors, FISH, microarrays, etc.), by chemical modification of nucleotides in any of their atoms. These properties show that ONs are first-order molecules due to their potential usefulness in practice.In this collection of research articles and review papers, we aim to highlight their therapeutic, but also diagnostic and technological utility as drugs. 2022-03-21T16:26:36Z 2022-03-21T16:26:36Z 2022 book ONIX_20220321_9783036530574_7 9783036530574 9783036530567 https://directory.doabooks.org/handle/20.500.12854/79571 eng image/jpeg Attribution 4.0 International https://mdpi.com/books/pdfview/book/4951 https://mdpi.com/books/pdfview/book/4951 MDPI - Multidisciplinary Digital Publishing Institute 10.3390/books978-3-0365-3056-7 10.3390/books978-3-0365-3056-7 46cabcaa-dd94-4bfe-87b4-55023c1b36d0 9783036530574 9783036530567 123 Basel open access
spellingShingle quantum dots (QDs)
DNAzyme
ROS
Amplex Red
light-induced activity
DNA methylation
histone code
microRNA
nanoparticles
noncoding RNA
pulmonary arterial hypertension
aptamer
aptasensor
influenza
SERS
virus detection
α-synuclein
antisense oligonucleotide
dopamine neurotransmission
double mutant A30P*A53T*
motor deficits
Parkinson’s disease
transgenic mouse model
G-quadruplexes
covalent dimer construct
anti-proliferative activity
primary cell culture of human glioma
antisensense oligonucleotide
Foxp3
regulatory T cells
vaccine immunogenicity
Sporothrix schenckii
Marfan syndrome
fibrillin-1
antisense oligonucleotides
exon skipping
splice-switching
thema EDItEUR::M Medicine and Nursing
Oligonucleotide, Therapy, and Applications
title Oligonucleotide, Therapy, and Applications
title_full Oligonucleotide, Therapy, and Applications
title_fullStr Oligonucleotide, Therapy, and Applications
title_full_unstemmed Oligonucleotide, Therapy, and Applications
title_short Oligonucleotide, Therapy, and Applications
title_sort oligonucleotide therapy and applications
topic quantum dots (QDs)
DNAzyme
ROS
Amplex Red
light-induced activity
DNA methylation
histone code
microRNA
nanoparticles
noncoding RNA
pulmonary arterial hypertension
aptamer
aptasensor
influenza
SERS
virus detection
α-synuclein
antisense oligonucleotide
dopamine neurotransmission
double mutant A30P*A53T*
motor deficits
Parkinson’s disease
transgenic mouse model
G-quadruplexes
covalent dimer construct
anti-proliferative activity
primary cell culture of human glioma
antisensense oligonucleotide
Foxp3
regulatory T cells
vaccine immunogenicity
Sporothrix schenckii
Marfan syndrome
fibrillin-1
antisense oligonucleotides
exon skipping
splice-switching
thema EDItEUR::M Medicine and Nursing
topic_facet quantum dots (QDs)
DNAzyme
ROS
Amplex Red
light-induced activity
DNA methylation
histone code
microRNA
nanoparticles
noncoding RNA
pulmonary arterial hypertension
aptamer
aptasensor
influenza
SERS
virus detection
α-synuclein
antisense oligonucleotide
dopamine neurotransmission
double mutant A30P*A53T*
motor deficits
Parkinson’s disease
transgenic mouse model
G-quadruplexes
covalent dimer construct
anti-proliferative activity
primary cell culture of human glioma
antisensense oligonucleotide
Foxp3
regulatory T cells
vaccine immunogenicity
Sporothrix schenckii
Marfan syndrome
fibrillin-1
antisense oligonucleotides
exon skipping
splice-switching
thema EDItEUR::M Medicine and Nursing
url ONIX_20220321_9783036530574_7